94 related articles for article (PubMed ID: 14681692)
1. Identification of multiple genetic loci that regulate adenovirus gene therapy.
Zhang HG; Hsu HC; Yang PA; Yang X; Wu Q; Liu Z; Yi N; Mountz JD
Gene Ther; 2004 Jan; 11(1):4-14. PubMed ID: 14681692
[TBL] [Abstract][Full Text] [Related]
2. Principal component analysis of quantitative trait loci for immune response to adenovirus in mice.
Musani SK; Zhang HG; Hsu HC; Yi N; Gorman BS; Allison DB; Mountz JD
Hereditas; 2006 Dec; 143(2006):189-97. PubMed ID: 17362354
[TBL] [Abstract][Full Text] [Related]
3. The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection.
Kafrouni MI; Brown GR; Thiele DL
J Leukoc Biol; 2003 Oct; 74(4):564-71. PubMed ID: 12960267
[TBL] [Abstract][Full Text] [Related]
4. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
[TBL] [Abstract][Full Text] [Related]
5. Quantitative trait loci for novelty/stress-induced locomotor activation in recombinant inbred (RI) and recombinant congenic (RC) strains of mice.
Gill KJ; Boyle AE
Behav Brain Res; 2005 Jun; 161(1):113-24. PubMed ID: 15904718
[TBL] [Abstract][Full Text] [Related]
6. Defective clearance of adenovirus in IRF-1 mice associated with defects in NK and T cells but not macrophages.
Xu X; Zhang HG; Liu ZY; Wu Q; Yang PA; Sun SH; Chen J; Hsu HC; Mountz JD
Scand J Immunol; 2004; 60(1-2):89-99. PubMed ID: 15238077
[TBL] [Abstract][Full Text] [Related]
7. Repeated intratracheal instillations of nonreplicating adenovirus 2 vector attenuate CTL responses and IFN-gamma production.
Pascual DW; Walters N; Hillemeyer P
J Immunol; 1998 May; 160(9):4465-72. PubMed ID: 9574552
[TBL] [Abstract][Full Text] [Related]
8. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
Leng J; Zhang L; Yao H; Cao X
Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
[TBL] [Abstract][Full Text] [Related]
10. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
Sung RS; Qin L; Bromberg JS
Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
[TBL] [Abstract][Full Text] [Related]
11. Immunological needles in the gene therapy haystack: applying a genetic paradigm to gene therapy.
Lowenstein PR
Gene Ther; 2004 Jan; 11(1):1-3. PubMed ID: 14681691
[No Abstract] [Full Text] [Related]
12. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
13. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
Stein CS; Pemberton JL; van Rooijen N; Davidson BL
Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
[TBL] [Abstract][Full Text] [Related]
14. Effective repeat administration with adenovirus vectors to the muscle.
Chen P; Kovesdi I; Bruder JT
Gene Ther; 2000 Apr; 7(7):587-95. PubMed ID: 10819574
[TBL] [Abstract][Full Text] [Related]
15. Novel loci regulating bone anabolic response to loading: expression QTL analysis in C57BL/6JXC3H/HeJ mice cross.
Kesavan C; Baylink DJ; Kapoor S; Mohan S
Bone; 2007 Aug; 41(2):223-30. PubMed ID: 17543594
[TBL] [Abstract][Full Text] [Related]
16. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD
Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
20. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
